SPRAVATO™ (esketamine) 

SPRAVATO™ (esketamine) CIII Nasal Spray is indicated, in conjunction with an oral antidepressant (AD), for the treatment of treatment-resistant depression (TRD) in adults.

To learn more about Spravato, click here.

We accept the following medical insurances: Please note there may be exclusions to your plan.

aetna.png
cigna.png
United.png
Contact Us